Anuradha Rao, etc.,al. Detection of highly pathogenic avian influenza A(H5N1) in contrived nasal swab specimens using commercial molecular influenza A tests. Open Forum Infectious Diseases
At least 70 human cases of highly pathogenic avian influenza (HPAI) A H5N1 (i.e., "bird flu") have been reported in the U.S. since 2024, primarily among individuals with exposure to dairy cattle or poultry. These cases, along with the rapid transmission of bird flu among U.S. wild bird, poultry, and cattle populations, warrant testing of available influenza A diagnostics for their ability to detect 2024 H5N1 strains. We previously tested 12 lateral flow assays (LFAs) and 5 point-of-care (POC) nucleic acid amplification tests (NAATs) with influenza A(H5N1) clade 2.3.4.4b (https://doi.org/10.1101/2025.04.15.25325613) as part of pandemic preparedness assessment. Here we expand the analysis by testing six additional FDA-cleared small footprint, sample-to-answer NAATs. The tests are anonymized pending authorization from each company.
See Also:
Latest articles in those days:
- The evolution and transmission dynamics of H3N2 influenza virus identified in a respiratory disease outbreak in companion dogs in Alabama, USA 4 hours ago
- Structural and functional characterization of hemagglutinin E190D and Q226H minor variants in human H5N1 A/British Columbia/PHL-2032/2024 4 hours ago
- Spatial risk factors associated with outbreaks of highly pathogenic avian influenza in Pennsylvania’s commercial poultry farms 4 hours ago
- [preprint]H9N2 avian influenza virus in Bangladesh: three genetically distinct co-circulating subgroups retain a largely conserved antigenic phenotype 4 hours ago
- [preprint]Endogenous serine proteases in MDCK sublines support trypsin-independent influenza A virus replication 4 hours ago
[Go Top] [Close Window]


